Iberiabank Corp boosted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 20.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,386 shares of the healthcare conglomerate’s stock after acquiring an additional 739 shares during the period. Iberiabank Corp’s holdings in UnitedHealth Group were worth $1,084,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of the stock. Crewe Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $25,000. Pearl River Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $35,000. Canton Hathaway LLC bought a new stake in UnitedHealth Group during the 1st quarter valued at $36,000. Laurel Wealth Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter worth $42,000. Finally, Truvestments Capital LLC bought a new position in UnitedHealth Group in the 1st quarter worth $42,000. 85.63% of the stock is owned by institutional investors.
Shares of UnitedHealth Group stock traded down $4.19 on Wednesday, hitting $243.47. 3,852,100 shares of the company traded hands, compared to its average volume of 4,907,021. The company’s 50-day moving average price is $244.67. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63. The firm has a market cap of $237.24 billion, a PE ratio of 18.90, a P/E/G ratio of 1.34 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the consensus estimate of $3.60 by $0.13. The business had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the company earned $3.04 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Inc will post 14.71 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a $1.08 dividend. The ex-dividend date of this dividend was Friday, June 14th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.90. This represents a $4.32 dividend on an annualized basis and a yield of 1.77%. UnitedHealth Group’s payout ratio is currently 33.54%.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $239.02, for a total value of $1,195,100.00. Following the sale, the director now owns 77,993 shares in the company, valued at $18,641,886.86. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $229.75, for a total value of $2,297,500.00. Following the completion of the sale, the director now owns 187,663 shares in the company, valued at approximately $43,115,574.25. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock valued at $8,392,500 over the last quarter. 0.82% of the stock is currently owned by corporate insiders.
Several brokerages have commented on UNH. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 27th. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 19th. Citigroup raised shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and upped their target price for the stock from $247.00 to $280.00 in a research report on Friday, May 10th. UBS Group initiated coverage on shares of UnitedHealth Group in a research report on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 price objective on the stock. Finally, SunTrust Banks dropped their price target on shares of UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a report on Wednesday, April 17th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $290.84.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Resistance Level
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.